TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
OMER

Omeros Corporation

Healthcare · Biotechnology

20.70$ -1.5% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet OMER
Line item 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – -20.2% +186.3% -26.4% -41.0% -1.5% -37.8% -32.9% +341.8% +37.3% +72.9% -17.5% +42.8% +32.2% +131.6% +41.0% -36.0% -26.8% +17.5%
– – – -16.3% +196.2% -27.9% -40.7% -4.8% -40.0% -38.2% +305.7% +62.2% +79.8% -17.1% +15.4% +45.8% +63.9% +78.8% -50.8% -38.4% +60.8%
– – – +114.8% -93.6% +299.8% +22.2% -62.0% -8.9% -74.4% +285.6% +62.9% +52.6% +72.7% -47.4% +240.5% +860.0% -89.1% -35.5% -52.1% +184.1%
– – – -17.0% +201.8% -30.4% -41.5% -9.0% -36.9% -51.2% +310.4% +60.4% +84.7% -27.8% +0.5% +122.0% +16.5% +23.9% -11.8% -47.6% +90.6%
– – – +8.9% +19.8% +496.4% -40.8% +120.8% -80.4% +3.4% +1,562.5% +84.7% +42.4% +33.1% +54.2% -89.1% +2,047.2% +193.4% -97.2% +447.6% -1.5%
– – – – – – – – – – -16.9% +139.0% -60.7% +11,753.5% -8.0% +137.2% -100.0% – – – –
– – – +9.4% +18.3% +49.4% -54.4% +40.3% -9.5% -16.7% +21.6% +24.2% +79.6% +81.3% -0.4% +633.3% +6.9% -22.5% – – –
– – – – – – – – – – – – – – – – – – – – –
– – – -63.4% – – – – – – – – – – – – – – – – –
– – – +16.2% -83.2% +33.4% +28.9% +641.2% -85.5% +53.9% +40.0% +39.2% +13.8% -103.5% – +22.7% +31.0% +27.8% -20.2% +14.0% -2.8%
– – – +196.9% -52.9% +43.1% +19.6% -50.9% +27.4% +55.2% -11.8% -1.1% +63.7% +42.0% +48.5% -33.8% +41.0% +163.3% -60.9% +49.2% -1.8%
– – – +1,539.2% -70.2% -92.0% +1,392.4% – – +15.1% -98.9% +171.2% +147.5% +81.4% +294.2% +7.9% +38.9% +1,778.0% -86.1% +96.4% -13.4%
– – – -52.1% +113.2% -8.5% -16.5% +31.5% -11.5% +111.0% +30.8% -60.8% +165.6% -6.1% -15.2% -21.2% +219.1% -55.3% +28.8% -23.4% -19.3%
– – – – +6,533.1% +19.6% +44.8% +48.4% -25.9% +77.2% +88.5% +59.8% +5.8% +77.1% +6.2% +49.3% +32.7% -29.5% -3.5% -21.8% +25.2%
– – – – – -52.6% -127.1% – – – – – – – -116.8% – – +260.3% -129.2% – –
– – – – – – – – – – – – – – -213.0% – – – – – –
– +0.0% +0.0% -24.7% -32.8% +196.7% +3.7% +8.7% +18.2% +16.4% +13.0% +7.7% +12.6% +6.7% +1.9% +15.5% +9.0% +0.6% +0.0% -7.3% +9.2%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?